Recent advances in the search for a targeted immunomodulatory therapy for primary Sjögren’s syndrome [version 1; peer review: 2 approved]
Primary Sjögren’s syndrome is a chronic autoimmune disease characterized by salivary and lacrimal gland dysfunction, leading to substantial morbidity and reduced quality of life. Many patients with primary Sjögren’s syndrome also have extraglandular systemic complications, some of which can be organ...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2019-08-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-1532/v1 |